High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

Rischin, Danny ; Hughes, Brett G M ; Basset-Séguin, Nicole ; Schadendorf, Dirk ; Bowyer, Samantha ; Trabelsi Messai, Sabiha ; Meier, Friedegund ; Eigentler, Thomas K ; Casado Echarren, Victoria ; Stein, Brian ; Beylot-Barry, Marie ; Dalac, Sophie ; Dréno, Brigitte ; Migden, Michael R ; Hauschild, Axel ; Schmults, Chrysalyne D ; Lim, Annette M ; Yoo, Suk-Young ; Paccaly, Anne J ; Papachristos, Apostolos ; Nguyen, Jenny-Hoa ; Okoye, Emmanuel ; Seebach, Frank ; Booth, Jocelyn ; Lowy, Israel ; Fury, Matthew G ; Guminski, Alexander

England: BMJ Publishing Group Ltd

Texto completo disponível

535 A phase I/II study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors

Lakhani, Nehal ; Johnson, Melissa ; Groisberg, Roman ; Han, Hyunsil ; Casey, Kerry ; Li, Siyu ; Skokos, Dimitris ; Seebach, Frank ; Lowy, Israel ; Fury, Matthew ; Mathias, Melissa

London: BMJ Publishing Group Ltd

Texto completo disponível

428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)

Lewis, Karl ; Peris, Ketty ; Sekulic, Aleksandar ; Stratigos, Alexander ; Dunn, Lara ; Eroglu, Zeynep ; Chang, Anne Lynn ; Migden, Michael ; Li, Siyu ; Mohan, Kosalai ; Coates, Ebony ; Okoye, Emmanuel ; Baurain, Jean-François ; Bechter, Oliver ; Hauschild, Axel ; Butler, Marcus ; Hernandez-Aya, Leonel ; Licitra, Lisa ; Neves, Rogerio ; Ruiz, Emily ; Seebach, Frank ; Weinreich, David ; Yancopoulos, George ; Lowy, Israel ; Bowler, Timothy ; Fury, Matthew

London: BMJ Publishing Group LTD

Texto completo disponível

Real-World Patient Characteristics, Treatment Patterns, and Outcomes Among Patients with Advanced Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab at US Oncology Clinical Practices

Ge, Wenzhen ; Wu, Ning ; Chen, Chieh-I ; Inocencio, Timothy J. ; LaFontaine, Patrick R. ; Seebach, Frank ; Fury, Matthew ; Harnett, James ; Ruiz, Emily

Texto completo disponível

Phase 2 study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 Groups 1, 2, and 3

Migden, Michael ; Schmults, Chrysalyne ; Khushalani, Nikhil ; Guminski, Alexander ; Chang, Anne Lynn ; Lewis, Karl ; Ansstas, George ; Bowyer, Samantha ; Hughes, Brett ; Schadendorf, Dirk ; Modi, Badri ; Dunn, Lara ; Flatz, Lukas ; Hauschild, Axel ; Yoo, Suk-Young ; Booth, Jocelyn ; Seebach, Frank ; Lowy, Israel ; Fury, Matthew ; Rischin, Danny

Texto completo disponível

Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6

Hughes, Brett ; Grob, Jean-Jacques ; Bowyer, Samantha ; Day, Fiona ; Ladwa, Rahul ; Stein, Brian ; Muñoz-Couselo, Eva ; Basset-Seguin, Nicole ; Guminski, Alexander ; Mortier, Laurent ; Hauschild, Axel ; Migden, Michael ; Schmults, Chrysalyne ; Yoo, Suk-Young ; Booth, Jocelyn ; Seebach, Frank ; Lowy, Israel ; Fury, Matthew ; Rischin, Danny

Texto completo disponível

Primary analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors

Lewis, Karl D ; Peris, Ketty ; Sekulic, Aleksandar ; Stratigos, Alexander J ; Dunn, Lara ; Eroglu, Zeynep ; Chang, Anne Lynn S ; Migden, Michael R ; Yoo, Suk-Young ; Mohan, Kosalai ; Coates, Ebony ; Okoye, Emmanuel ; Baurain, Jean-François ; Bechter, Oliver ; Hauscild, Axel ; Butler, Marcus O ; Hernandez-Aya, Leonel ; Licitra, Lisa ; Neves, Rogerio I ; Ruiz, Emily S ; Seebach, Frank ; Lowy, Israel ; Goncalves, Priscila ; Fury, Matthew G

Texto completo disponível

Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up

Stratigos, Alexander J ; Sekulic, Aleksandar ; Peris, Ketty ; Bechter, Oliver ; Prey, Sorilla ; Kaatz, Martin ; Lewis, Karl D ; Basset-Seguin, Nicole ; Chang, Anne Lynn S ; Dalle, Stéphane ; Orland, Almudena Fernandez ; Licitra, Lisa ; Robert, Caroline ; Ulrich, Claas ; Hauschild, Axel ; Migden, Michael R ; Dummer, Reinhard ; Yoo, Suk-Young ; Coates, Ebony ; Okoye, Emmanuel ; Bassukas, Ioannis ; Loquai, Carmen ; De Giorgi, Vincenzo ; Eroglu, Zeynep ; Gutzmer, Ralf ; Ulrich, Jens ; Puig, Susana ; Seebach, Frank ; Lowy, Israel ; Fury, Matthew G

Texto completo disponível

Interim Analysis of Phase 2 Results for Cemiplimab in Patients with Metastatic Basal Cell Carcinoma (mBCC) who Progressed on or are Intolerant to Hedgehog Inhibitors (HHIs)

Lewis, Karl ; Peris, Katty ; Sekulic, Aleksandar ; Stratigos, Alexander ; Dunn, Lara ; Eroglu, Zeynep ; Chang, Anne Lynn ; Migden, Michael ; Li, Siyu ; Yoo, Suk-Young ; Mohan, Kosalai ; Coates, Ebony ; Okoye, Emmanuel ; Baurain, Jean-Francois ; Bechter, Oliver ; Hauschild, Axel ; Butler, Marcus ; Hernandez-Aya, Leonel ; Licitra, Lisa ; Neves, Rogerio ; Ruiz, Emily ; Seebach, Frank ; Lowy, Israel ; Bowler, Timothy ; Fury, Matthew

Sem texto completo

Primary Analysis of Phase 2 Results for Cemiplimab in Patients (pts) with Locally Advanced Basal Cell Carcinoma (laBCC) who Progress on or are Intolerant to Hedgehog Inhibitors (HHIs)

Stratigos, Alexander ; Sekulic, Aleksandar ; Peris, Ketty ; Bechter, Oliver ; Kaatz, Martin ; Lewis, Karl ; Basset-Segiun, Nicole ; Chang, Anne Lynn ; Dalle, Stephanie ; Orland, Almudena Fernandez ; Licitra, Lisa ; Robert, Caroline ; Ulrich, Claas ; Hauschild, Axel ; Migden, Michael ; Dummer, Reinhard ; Li, Siyu ; Mohan, Kosalai ; Coates, Ebony ; Jankovic, Vladimir ; Flaschi, Nathalie ; Okoye, Emmanuel ; Bassukas, Ioannis ; Loquai, Carmen ; De Giorgi, Vincent ; Eroglu, Zeynep ; Gutzmer, Ralf ; Ulrich, Jens ; Puig, Susana ; Seebach, Frank ; Thurston, Gavin ; Lowy, Israel ; Bowler, Timothy ; Fury, Matthew

Sem texto completo